What is the significance of a T-SPOT.TB result with an antigen spot count of 2 (level 2), a nil (negative control) spot count of 3, and a mitogen (positive control) spot count greater than 20?

T-SPOT.TB Result Interpretation: Indeterminate Test

This T-SPOT.TB result is indeterminate and cannot be used to determine whether Mycobacterium tuberculosis infection is present or absent. You must repeat the test or use alternative diagnostic methods.

Why This Result is Indeterminate

According to the CDC/MMWR interpretation criteria 1111, your result meets the definition of an indeterminate test based on the following parameters:

• Nil (negative control): 3 spots - This is acceptable (≤10 spots required)
• TB antigen response: 2 spots - This is below the threshold for any interpretation
• Mitogen (positive control): >20 spots - This is adequate and confirms immune competence

The critical issue is that the TB antigen spot count of 2 is below 5 spots. Per the official interpretation table 111, when:

• Nil ≤10 spots AND
• TB response <5 spots AND
• Mitogen <20 spots

The result is indeterminate, indicating an uncertain likelihood of M. tuberculosis infection.

However, your mitogen control is adequate (>20), which means the patient's immune system responded appropriately to the positive control. This creates a borderline situation where the low antigen response (2 spots) falls into the indeterminate zone because it's too low to be negative (which requires ≤4 spots with adequate controls) but the specific combination of values doesn't clearly fit the negative category.

Clinical Significance

What This Means:

• The test cannot rule in or rule out TB infection
• The patient's T-cells are functional (proven by adequate mitogen response >20)
• The low background (nil = 3) is acceptable and doesn't interfere with interpretation
• The TB antigen response is simply too low to interpret definitively

Why Spot Count of 2 is Problematic:

According to the interpretation criteria 11:

• Negative: Requires ≤4 spots with nil ≤10 and adequate mitogen
• Borderline: Requires 5-7 spots
• Positive: Requires ≥8 spots

Your result of 2 spots technically falls in the negative range numerically, but some laboratories and studies have used varying cutoffs 11. The manufacturer's criteria state that with nil ≤10 spots and TB response ≤4 spots, the test should be negative if mitogen is adequate. However, values this close to background (nil = 3, antigen = 2) represent minimal immune response and warrant cautious interpretation.

Recommended Actions

Immediate next steps:

1. Repeat the T-SPOT.TB test - This is the most straightforward approach, as technical factors, timing of blood draw, or transient immune suppression can affect results 2

2. Consider clinical context carefully:

   • If high clinical suspicion for active TB exists (symptoms, imaging findings, epidemiologic risk), do not rely on this indeterminate result - proceed with additional microbiological testing (sputum cultures, molecular testing) 34
   • If screening for latent TB in low-risk patient, the indeterminate result suggests low likelihood of infection, but confirmation is needed

3. Alternative testing options:

   • Perform tuberculin skin test (TST) as confirmatory test 5
   • Consider QuantiFERON-Gold In-Tube as alternative IGRA
   • In immunocompromised patients, both tests may be needed 5

Important Caveats

Factors That Can Cause Low Spot Counts:

• Immunosuppression (though your adequate mitogen response argues against this) 36
• Early infection (insufficient time for immune response to develop) 1
• Advanced age - older patients have lower spot counts 34
• Timing of blood processing - delays can reduce spot counts 7
• Technical variation between readers and laboratories 7

Do NOT Interpret This As:

• ❌ Negative for TB infection (the spot count is too borderline)
• ❌ Positive for TB infection (clearly below the 8-spot threshold)
• ❌ Evidence of active vs. latent TB (IGRAs cannot distinguish these) 86

Special Populations:

In patients with malignancy 6, COPD 3, or receiving high-dose steroids (>40mg/day) 6, false-negative and indeterminate results are more common. If your patient falls into these categories, strongly consider repeat testing or alternative diagnostic approaches.

The bottom line: This indeterminate result provides no actionable information about TB infection status. Repeat testing is mandatory before making clinical decisions about TB treatment or clearance.